Clinical Trials Directory

Trials / Unknown

UnknownNCT03964662

Stroke Home Rehabilitation With WeReha

A New Solution for Home Rehabilitation of Stroke Patients: WeReha

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
150 (estimated)
Sponsor
CoRehab s.r.l. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

WeReha is an innovative device for the home rehabilitation of stroke patients developed within the scope of the EU funded project MAGIC-PCP \[5\]. WeReha is a system that allows patients to perform exercises in a home environment with remote supervision integrated within regular rehabilitation. The principle on which the product is based is that of biofeedback guided rehabilitation, designed to stimulate muscle recovery and contribute to a more effective and more motivating rehabilitation of neuro-motor patterns. WeReha is completely adaptable, allowing only authorized to assign exercises, by planning specific sequences of movements. WeReha product is composed by the following elements: * a tablet with a proprietary application on it (the "WeReha app") * an inertial sensor with accelerometers, gyroscopes and magnetometers (the "sensor") * elastic straps allowing the user to wear it on different parts of the body (the "straps") * a series of 3D printed objects where the sensor can be placed that become animated (the "smart objects") * a web portal for clinical staff through which they can manage and monitor users (the "web-application") The WeReha app presents the patient with a series of rehabilitation exercises in the form of a number of interactive games, driven by body movement, which is captured by the sensor or the hand specific movements using the smart objects. A session with WeReha always starts with a questionnaire on the system, through which the software gains an understanding of the patient's health conditions and the presence or not of a caregiver for the session. Based on this questionnaire, the software adapts the daily session to minimise risks while maintaining a high level of rehabilitation to help the patient reach their goals. The device works with and without an internet connection, but when the device is connected to the internet, supervisors are able to provide supervision and remote support through a web application. The web application is hosted on a dedicated server located inside the hospital. Only trained staff will be provided with access to the web application with a unique username and password required for sign on. The exercises assigned for the client to perform at home, are at the discretion of the clinician who is caring for the patient and might require the presence of a caregiver. The goal of this study is to investigate the applicability and utility of an innovative technology product such as WeReha to the home rehabilitation of stroke patients as an integrative solution to a conventional exercise program and to assess its acceptance by the patient, caregivers and clinic professionals. Patients will use WeReha for their home rehabilitation in addition to traditional treatments for up to 12 weeks. The Inclusion criteria for the study have been kept broad in order to assess these factors on a large enough scale, so as not to limit the usage of the device to a specific sub-group of patients. If patients enrolled are in a subacute phase (i.e. within the first 6 months after the stroke onset), they will be enrolled before leaving the hospital or the rehabilitation department and reaching their home. If patients are considered to be in their chronic phase (i.e. over 6 months after stroke onset), they will be enrolled during an outpatient treatment or on a volunteer basis. Before starting the trial with WeReha, every patient enrolled will receive proper training from a person dedicated to the project (who will be referred to as the "dedicated figure") appointed by the hospital and financially supported by the sponsor of the study.

Conditions

Interventions

TypeNameDescription
DEVICEWeRehaRehabilitation of stroke patients with the device WeReha

Timeline

Start date
2018-12-18
Primary completion
2020-02-28
Completion
2020-02-28
First posted
2019-05-28
Last updated
2019-06-18

Locations

3 sites across 2 countries: Italy, United Kingdom

Source: ClinicalTrials.gov record NCT03964662. Inclusion in this directory is not an endorsement.